Back

Acute nasal dryness in COVID-19

Navarra, J.; Ruiz-Ceamanos, A.; Moreno, J. J.; Garcia-Basterrechea, J. M.; de Haro-Licer, J.; Sinnett, S.; Spence, C.; Gallardo-Pujol, D.

2020-11-19 infectious diseases
10.1101/2020.11.18.20233874 medRxiv
Show abstract

One of the entry routes of SARS-CoV-2 is the nasal epithelium. Although mounting evidence suggests the presence of olfactory dysfunction, and even anosmia, in patients with COVID-19, it is not clear whether these patients also suffer from other "nasal" symptoms that may influence their olfaction. A group of 35 patients with COVID-19 (and a control group matched in gender and age) were surveyed about the presence of a variety of nasal symptoms that may be associated to drastic perturbations experienced in the nasal cavity (e.g., "excessive dryness" and/or a continual sensation of having had a "nasal douche"). We used a cross-sectional, retrospective survey, targeted at the general population by means of non-quoted, non-random, snowball sampling. Symptoms were assessed with absence/presence responses. The possible association between two continuously distributed latent variables from categorical variables was estimated by means of polychoric correlations. More than 68% of the patients reported at least one "nasal" symptom. The clinical group also experienced "a strange sensation in the nose" and having excessive nasal dryness significantly more often than the control group. Fifty-two percent of the patients (but only 3% of the control group) reported a constant sensation of having had a strong nasal douche. Nasal symptoms predominantly co-occurred with anosmia/hyposmia, and ageusia/hypogeusia, appeared principally before or during the other symptoms of COVID-19, and lasted for twelve days, in average. The presence of these nasal symptoms, and their early occurrence, could potentially facilitate early diagnosis of COVID-19 and initial social distancing efforts.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Chemical Senses
30 papers in training set
Top 0.1%
42.0%
2
Scientific Reports
3102 papers in training set
Top 3%
13.3%
50% of probability mass above
3
PLOS ONE
4510 papers in training set
Top 16%
10.8%
4
Translational Psychiatry
219 papers in training set
Top 2%
2.8%
5
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.3%
1.8%
6
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.4%
7
Frontiers in Neurology
91 papers in training set
Top 4%
1.3%
8
mSphere
281 papers in training set
Top 4%
1.3%
9
International Journal of Molecular Sciences
453 papers in training set
Top 11%
1.0%
10
Journal of Medical Virology
137 papers in training set
Top 4%
0.8%
11
Clinical Infectious Diseases
231 papers in training set
Top 5%
0.7%
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 46%
0.7%
13
eLife
5422 papers in training set
Top 60%
0.7%
14
ERJ Open Research
44 papers in training set
Top 0.9%
0.7%
15
JCI Insight
241 papers in training set
Top 9%
0.5%
16
The Journal of Infectious Diseases
182 papers in training set
Top 6%
0.5%
17
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 5%
0.5%
18
Journal of the Endocrine Society
11 papers in training set
Top 0.5%
0.5%
19
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 7%
0.5%
20
Journal of Clinical Investigation
164 papers in training set
Top 8%
0.5%
21
Viruses
318 papers in training set
Top 6%
0.5%
22
Infection
15 papers in training set
Top 0.5%
0.5%
23
Pediatric Pulmonology
14 papers in training set
Top 0.4%
0.5%